Working to reduce brain injury in newborns

November 10, 2017, Children's National Medical Center
Credit: CC0 Public Domain

Research-clinicians at Children's National Health System led the first study to identify a promising treatment to reduce or prevent brain injury in newborns who have suffered hypoxia-ischemia, a serious complication in which restricted blood flow deprives the brain of oxygen.

Consequences of resulting from affect the entire lifespan and range from mild (learning disabilities) to severe (inability to breathe, walk, talk or see). This complication can occur during or before birth due to maternal/placental problems, such as placental abruption or cord prolapse, or due to fetal/newborn issues, such as asphyxia due to labor difficulties, infection, fetal-maternal bleeding or twin-to-twin transfusion.

Published in Neonatology on Oct. 13, 2017, the study evaluated newborn exposed to hypoxia-ischemia. The experimental models were given standard cooling therapy () alone and in combination with a selective Src kinase inhibitor, PP2, that blocks a regulatory enzyme of apoptosis (cell death), which intensifies as a result of hypoxia-ischemia. The Food and Drug Administration has approved a Src kinase inhibitor as an oncology treatment. This study is the first to test the benefits of blocking this enzyme in reducing the neurological damage caused by hypoxia-ischemia.

"In hypoxia-ischemia, CaM kinase is over-activated, but has been shown to decrease this enzyme's activation. We theorized that a Src kinase inhibitor, in addition to hypothermia, would further attenuate the activation of CaM kinase IV and that the result might be less brain damage," explains Panagiotis Kratimenos, M.D., Ph.D., the study's lead author, and a specialist in neonatology and neonatal neurocritical care at Children's National. "From this study, we were pleased that this seems to be the case."

The research team assessed neuropathology, adenosine triphosphate and phosphocreatine concentrations as well as CaM kinase IV activity. The CaM kinase IV activity in cerebral tissue was 2,002 (plus or minus 729) with normal oxygen levels and in normal temperatures, 4,104 (plus or minus 542) in hypoxia with , and 2,165 (plus or minus 415) in hypoxia with hypothermia treatment combined with PP2 administration.

The authors conclude that hypothermia alone attenuated the over-activation of CaM kinase IV and improved neuropathology after hypoxia. However, the combination of hypothermia with Src kinase inhibition following hypoxia further attenuated the increased activation of CaM kinase IV, compared with hypothermia alone in the newborn experimental model brain.

Currently, the only treatment for hypoxia-ischemia is therapeutic hypothermia. Starting in the first six hours of life, doctors in the neonatal intensive care unit lower a baby's temperature by about 3 degrees Celsius for three days. This therapy is proven to reduce neural defects by up to 30 percent, yet many infants still have poor outcomes even after the therapeutic cooling treatment.

"In oxygen deprivation of the brain, the pathways leading to cell death are over-activated, including the nuclear enzyme CaM IV. We sought to intervene in this pathway to reduce the heightened , which leads to brain damage," explains Dr. Kratimenos, an assistant professor of pediatrics at The George Washington University School of Medicine and Health Sciences whose research focus is neonatal encephalopathy and therapeutic hypothermia.

To continue preclinical research into this approach, Dr. Kratimenos envisions studying the effect of other types of small molecule inhibitors to target the apoptotic cascade, perhaps in multiple doses, eliminating the potential side effects, and determining the best dose and duration of treatment.

"If confirmed by further studies, this approach—in combination with cooling—may help to further attenuate neurological damage that babies suffer after experiencing hypoxia-ischemia," says Dr. Kratimenos.

Explore further: Hypothermia after stroke reduces dynamin levels and neuronal cell death

More information: Panagiotis Kratimenos et al, Effect of Concurrent Src Kinase Inhibition with Short-Duration Hypothermia on Ca2+/Calmodulin Kinase IV Activity and Neuropathology after Hypoxia-Ischemia in the Newborn Swine Brain, Neonatology (2017). DOI: 10.1159/000480067

Related Stories

Hypothermia after stroke reduces dynamin levels and neuronal cell death

August 16, 2017
A new study has shown that following brain ischemia caused by cerebral blockage in mice both immediate and delayed reduction in body temperature helped limit cell death and levels of a protein called dynamin. These results, ...

Multi-mechanism approach to treating neonatal hypoxic ischemia

September 1, 2017
Hypothermia alone, the current standard of care, neuroprotects roughly 50 percent of newborns with moderate to severe hypoxic ischemia. Therefore, half of all affected newborns are left with developmental, cognitive and motor ...

Cooling treatment reduces epilepsy in children

October 3, 2017
Cooling babies deprived of oxygen at birth (perinatal asphyxia) can reduce the number of children who develop epilepsy later in childhood, according to a new study published in the journal Epilepsia.

Researchers discover cause of brain sensitivity to lack of oxygen

October 30, 2017
Researchers at Maastricht University Medical Center and Maastricht University have discovered why the brain is more sensitive to oxygen deprivation, or hypoxia, than other organs. Hypoxia caused by a stroke, for example, ...

Continuous EEG better at identifying oxygen-deprived newborns most at risk

October 25, 2017
Continuously recording the brain's electrical signals and examining how those impulses evolve over time is a more reliable way to identify infants at risk for brain injury, compared with doing snapshot evaluations, according ...

New study data show reduced intracranial pressure

July 28, 2015
Results from a European clinical trial comparing therapeutic hypothermia to standard treatment for patients with elevated intracranial pressure (ICP) as a result of severe traumatic brain injury demonstrate a significant ...

Recommended for you

Both quantity and quality of sleep affect cardiovascular risk factors in adolescents

June 15, 2018
A study from a research team led by a MassGeneral Hospital for Children (MGHfC) physician finds that both the quantity and quality of sleep—the amount of time spent sleeping and the percentage of sleep that is undisturbed—in ...

Ingesting honey after swallowing button battery reduces injury and improves outcomes

June 11, 2018
A team of ear, nose, and throat (ENT) specialists has demonstrated that eating honey after swallowing a button battery has the potential to reduce serious injuries in small children. Based on findings in laboratory animals, ...

Bifidobacteria supplement colonizes gut of breastfed infants

June 10, 2018
Supplementing breastfed infants with activated Bifidobacterium infantis (B. infantis) bacteria had a positive impact on babies' gut microbes for up to a year, according to a recent study by researchers at the University of ...

Fish oil may protect the youngest hearts

June 8, 2018
(HealthDay)—Omega-3 fatty acids—good fats found in fish—can boost the heart health of adults, but a new study suggests that babies might also stand to benefit from them.

Asthma and flu: a double whammy

June 4, 2018
Asthma and respiratory viruses don't go well together. Weakened by the common cold or the flu, a person suffering an asthma attack often responds poorly to emergency treatment; some must be hospitalized. This is especially ...

Preschool program preps kids for academic success through elementary school

June 4, 2018
A program that helps low-income parents prepare their children for school has benefits that extend beyond kindergarten and into into third grade, according to Penn State researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.